Shanghai Junshi Biosciences Co., Ltd.
SSE:688180.SS
35.75 (CNY) • At close June 16, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -1,359.028 | -2,489.887 | -2,675.202 | -592.648 | -1,669.461 | -763.124 | -717.566 | -321.013 | -131.726 | -57.97 | -25.254 |
| Depreciation & Amortization
| 283.875 | 303.22 | 293.654 | 262.559 | 151.362 | 59.591 | 30.206 | 18.319 | 8.656 | 7.118 | 2.954 |
| Deferred Income Tax
| 0 | 0 | -139.877 | -173.817 | -5.682 | 8.716 | 17.167 | -0.361 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 23.977 | 91.911 | 192.754 | 30.728 | 11.797 | 21.7 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -531.035 | -327.857 | 687.188 | -318.773 | -13.068 | -464.067 | 126.685 | -27.568 | -33.501 | -13.005 | -5.036 |
| Accounts Receivables
| -7.491 | -314.418 | 1,229.75 | -770.558 | -482.174 | -410.446 | -51.926 | -36.819 | -45.166 | -13.005 | -5.036 |
| Inventory
| -114.596 | -32.448 | -136.394 | -154.823 | -166.986 | -132.198 | -18.963 | -23.517 | -4.311 | 0 | 0 |
| Accounts Payables
| 0 | 262.672 | -505.728 | 702.327 | 685.967 | 86.023 | 189.9 | 28.925 | 8.731 | 0 | 0 |
| Other Working Capital
| -408.948 | -243.663 | 99.56 | -95.719 | -49.874 | -7.446 | 145.648 | -4.051 | -29.19 | 0 | 0 |
| Other Non Cash Items
| 163.347 | 485.565 | -32.999 | -11.976 | 7.315 | -39.947 | 11.05 | -16.814 | -28.636 | -18.171 | -11.854 |
| Operating Cash Flow
| -1,442.841 | -2,004.982 | -1,775.325 | -641.901 | -1,498.806 | -1,187.034 | -510.758 | -347.076 | -185.207 | -82.028 | -39.19 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -684.199 | -832.575 | -393.952 | -886.228 | -592.682 | -863.149 | -557.371 | -333.926 | -199.789 | -73.002 | -42.904 |
| Acquisitions Net
| 345.523 | 7.097 | -93.78 | -440.084 | 2.9 | -73.746 | 1.254 | 1.556 | -1.585 | 0 | 0 |
| Purchases Of Investments
| -2,094.062 | -1,399.008 | -8.484 | -1,169.62 | -245.166 | -117.346 | -403.5 | -1,176 | -1,148.825 | 0 | 0 |
| Sales Maturities Of Investments
| 1,500.72 | 1,246.871 | 91 | 565.284 | 70.135 | 72.2 | 513.77 | 1,610.346 | 683.687 | 0 | 0 |
| Other Investing Activites
| 54.544 | 44.424 | -62.403 | 49.696 | 66.837 | 30.011 | 24.866 | 85.736 | -50.664 | 138.561 | -119.5 |
| Investing Cash Flow
| -877.474 | -933.191 | -467.619 | -1,880.952 | -697.976 | -952.03 | -420.981 | 187.712 | -717.176 | 65.559 | -162.404 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 1,132.731 | 496.18 | 726.917 | -293.333 | -52.525 | 292.379 | 528.132 | 0 | -1 | 0 | 0 |
| Common Stock Issued
| 0 | 152.595 | 3,812.264 | 2,150.127 | 4,846.934 | 403.838 | 3,012.894 | 319.7 | 648.692 | 0 | 0 |
| Common Stock Repurchased
| -4.001 | -26.891 | 0 | 0 | 0 | 0 | -1.745 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | -19.158 | -16.691 | -43.157 | -58.599 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -111.893 | 89.944 | 103.828 | 808.892 | 4,509.205 | 359.802 | -106.679 | -0.066 | -1.406 | 349.989 | 179.658 |
| Financing Cash Flow
| 1,016.837 | 711.828 | 4,643.009 | 2,665.686 | 4,413.523 | 593.582 | 3,432.602 | 319.634 | 646.286 | 349.989 | 179.658 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 12.015 | 7.551 | 92.266 | -23.226 | -45.768 | -4.062 | -3.591 | -5.359 | 3.556 | 0.616 | -0.22 |
| Net Change In Cash
| -1,291.463 | -2,218.794 | 2,492.331 | 119.607 | 2,170.972 | -1,549.544 | 2,497.272 | 154.911 | -252.541 | 334.136 | -22.155 |
| Cash At End Of Period
| 2,486.679 | 3,778.142 | 5,996.936 | 3,504.605 | 3,384.998 | 1,214.026 | 2,763.57 | 266.298 | 111.387 | 363.928 | 29.792 |